Nimotuzumab for COVID-19: case series.

Autor: Abdo Cuza AA; Intensive Care Unit. Medical & Surgical Research Center (CIMEQ), Havana, Cuba., Ávila JP; Intensive Care Unit. Medical & Surgical Research Center (CIMEQ), Havana, Cuba., Martínez RM; Intensive Care Unit. Medical & Surgical Research Center (CIMEQ), Havana, Cuba., González JJ; Radiology Department. Medical & Surgical Research Center (CIMEQ), Havana, Cuba., Aspuro GP; Intensive Care Unit. Medical & Surgical Research Center (CIMEQ), Havana, Cuba., Gutiérrez Martínez JA; Intensive Care Unit. Medical & Surgical Research Center (CIMEQ), Havana, Cuba., Suzarte MR; Clinical Research Direction. Center of Molecular Immunology (CIM), Havana, Cuba., Hernández DS; Clinical Research Direction. Center of Molecular Immunology (CIM), Havana, Cuba., Añé-Kouri AL; Clinical Research Direction. Center of Molecular Immunology (CIM), Havana, Cuba., Ramos TC; Clinical Research Direction. Center of Molecular Immunology (CIM), Havana, Cuba.

Publikováno v: Immunotherapy [Immunotherapy] 2021 Nov 22. Date of Electronic Publication: 2021 Nov 22.